Dauntless Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development of specialty drugs. Our innovative one-asset, one-company model facilitates operational efficiency, drug development speed, and a simplified business development structure, leading to lower costs, shorter timelines and higher returns. Unlike a traditional biotech company which holds numerous assets at various stages of development, and its investors, management, labs, and staff collectively share interest in all company assets, Dauntless uses a one-asset, one-company model where each asset is held in a separate holding company. Dauntless manages the development of each asset and employs expert consultants who specialize in the unique requirements of a given asset. For more information, visit www.dauntlessph.com or e-mail us at info@dauntlessph.com.
Looking for a particular Dauntless Pharmaceuticals, Inc. employee's phone or email?
The Dauntless Pharmaceuticals, Inc. annual revenue was $10.4 million in 2026.
Dauntless Pharmaceuticals, Inc. is based in San Diego, California.
The NAICS codes for Dauntless Pharmaceuticals, Inc. are [3254, 51, 512, 32541, 325, 32].
The SIC codes for Dauntless Pharmaceuticals, Inc. are [28, 283, 78, 781].